SELLAS Life Sciences Group, Inc.
(SLS - NASDAQ)
11,59 USD
📋 Profilo Aziendale

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

|